Biotech Advisory Lab
↗Basel, Switzerland
Biotech Advisory Lab is a strategic advisory firm that provides independent, structured guidance to early-stage biotechnology companies as they transition from discovery into clinical development. The firm focuses on helping biotech teams maintain strategic control and financial visibility during the critical phase of entering first-in-human studies.
The company operates under a four-level advisory model: Level 1 (Clinical Readiness), Level 2 (Clinical Transition Structuring), Level 3 (Budget & Vendor Evaluation), and Level 4 (Ongoing Strategic Oversight). By remaining fully independent and avoiding commission-based models with CROs, the lab provides unbiased benchmarking of vendor proposals and operational feasibility assessments.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Revenue:Under $1M (Estimated)
Founded:2024
Ownership:private
Status:operating
FUNDING
Stage:Self-funded / Boutique
PIPELINE
Stage:Commercial
Lead Drug Stage:N/A (Service Provider)
Modalities:Small molecule, Biologics, Cell & Gene Therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
CORPORATE STRUCTURE
Key Partnerships:Venture Capital Firms, Biotech Incubators, Early-stage Biotech Startups
COMPETITION
Position:Niche Player
Competitors:Halloran Consulting Group, Pearl IRB, WCG, Bionest Partners, Cello Health
LEADERSHIP
Key Executives:
Anthony Pino - Founder & Managing Director
Scientific Founders:Anthony Pino
LINKS
Website:biotechadvisorylab.com
LinkedIn:LinkedIn Profile
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of Biotech Advisory Lab and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Biotech Advisory Lab. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.